HOME
ABOUT US
TECHNOLOGY
PIPELINE
PARTNERSHIP
MEDIA
RECRUITMENT
CONTACT
NEWS REPORT
GeneQuantum Healthcare joins Johnson & Johnson Innovation JLABS @ Shanghai becoming its 100th resident company
WCLC 2024: The latest research results of the new generation HER2 ADC GQ1005 are unveiled
01
GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs
GeneQuantum and WuXi XDC have entered into strategic cooperation to empower innovative bioconjugates development
GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate
GeneQuantum Healthcare was awarded the honorary title of " Unicorn-to-be" in Jiangsu Province and the recognition of "Enterprise Technology Center" in Suzhou
Genequantum Successfully Granted a "Unicorn-to-be" Company
